Skip to main content
Journals

The Invisible Scar: Energy-Based Facial Tightening Through the Lens of the Deep-Layer Facelift Surgeon

Aesthetic Surgery Journal
Aesthetic Surgery Journal

Authors: Tara M Chadab, MD, MS , Aaron L Wiegmann, MD, MS , Rod J Rohrich, MD
Abstract: Energy-based devices are widely used for facial rejuvenation; as a result, an increasing proportion of patients presenting for facelift or necklift surgery have a history of prior treatment with ultrasound- or radiofrequency-based technologies. While the efficacy and safety of these devices are well established, their cumulative effects on facial soft tissues critical to deep-layer facelift surgery remain under-recognized. This article examines three commonly used energy-based facial tightening modalities—microfocused ultrasound, high-frequency parallel beam ultrasound, and fractional radiofrequency microneedling—from the perspective of the facelift surgeon. Device-specific mechanisms of action and tissue-level effects are reviewed, followed by discussion of their potential operative implications and the senior author's experience-informed strategies for managing these patients. Recognition of these effects is essential for patient counseling, operative planning, and preservation of long-lasting surgical outcomes.

JOURNAL ARTICLE

Related Articles

Recurrent herpes labialis (RHL) is a common condition characterized by episodic viral reactivation triggered by local or systemic factors. Hyaluronic acid (HA) lip augmentation is widely performed for aesthetic purposes, yet its potential association with changes in herpes labialis recurrence has not been systematically evaluated. The aim of this study was to investigate whether repeated lip augmentation with HA filler is associated with changes in the incidence of RHL episodes over time.
AbobotulinumtoxinA (aboBoNT-A; Dysport®) is approved in China for treating glabellar lines (GLs) with fast onset of action (median: 2 days) and effectiveness up to 6 months (Chinese pivotal trial data), but real-world data remain limited. This study’s primary objective is to assess patient satisfaction following 3 cycles of aboBoNT-A treatment for moderate-to-severe GLs in a real-world setting.
Poly-L-lactic acid (PLLA) is a biostimulatory injectable that restores midfacial volume through collagen neogenesis rather than gel-based filling. Controlled clinical evidence directly quantifying PLLA's volumetric efficacy remains limited. This study aimed to evaluate the efficacy, safety, and patient-reported outcomes of a Norberg Medical PLLA formulation for midface rejuvenation in a prospective, evaluator-blinded, split-face controlled study.